Wholesale Acquisition Cost Information for Colorado Prescribers VYVGARTTM (efgartigimod-fcab)
Colorado law requires prescription drug manufacturers to disclose in writing to Colorado prescribers the Wholesale Acquisition Cost (“WAC”) of marketed drugs when engaging in prescription drug marketing. This disclosure provides the WAC price for the product listed below.
| NDC | argenx Product | Dosage Form | Strength | Unit Size | Wholesale Acquisition Cost* |
| 73475-3041-5 | VYVGART (efgartigimod alfa-fcab) | Solution in Vial Injection | 400 mg in 20 mL (20 mg/ml) Single Dose Vial | Single Use Vial | $5950.00 as of Dec 27, 2021 |
The price to acquire the product listed may differ from the WAC price listed. How much a patient will pay will depend on the patient’s insurance coverage. To find out the exact cost of a prescription, patients should contact their health insurance company.
Colorado law also requires manufacturers to provide the names of generic prescription drugs from the same “therapeutic class” as the marketed products. Colorado defines “therapeutic class” as “a group of similar drugs that have the same or similar mechanisms of action and are used to treat a specific condition.” There are currently no generic prescription drugs in the same “therapeutic class” (based on the definition of “therapeutic class” under Colorado law) as the listed argenx product.
*Pricing as of December 27, 2021. The pricing information disclosed above represents the WAC price, which represents the manufacturer’s published catalog or list price for a drug product to wholesalers as reported to third-party drug pricing publishers. WAC does not represent actual transaction prices and does not include other discounts, rebates or reductions in price. Pricing information listed does not imply safety or efficacy of the products, and no comparisons should be made.
VYVGART is a registered trademark of argenx.
©December 2021 argenx US, Inc.
US-EFG-21-00374 v2 12/2021